Bio Solutions Inc. Emergent Net Worth

What's Bio Emergent's mailing address?

Bio's mailing address filed with the SEC is 400 PROFESSIONAL DR, SUITE 400, , GAITHERSBURG, MD, 20879.

Insiders trading at Aptevo Therapeutics Inc

Over the last 8 years, insiders at Aptevo Therapeutics Inc have traded over $17,157,676 worth of Aptevo Therapeutics Inc stock and bought 1,998,342 units worth $25,387,921 . The most active insiders traders include Kevin Ctang Capital Managem..., Fuad El Hibri und Daniel Abdun Nabi. On average, Aptevo Therapeutics Inc executives and independent directors trade stock every 38 days with the average trade being worth of $22,185. The most recent stock trade was executed by So Young Kwon on 8 August 2024, trading 213 units of APVO stock currently worth $77.

What does Aptevo Therapeutics Inc do?

aptevo therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. we leverage the innovative adaptir™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. based in seattle, washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. as a result, aptevo has been able to attract some of the most innovative minds in the field. many of our team members have notable experience with other pioneering biotech companies including trubion, zymogenetics, immunex, dendreon, and vlst. at aptevo therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning aptevo therapeutics to develop the science of what’s next in biotechnology.

Aptevo Therapeutics Inc executives and stock owners

Aptevo Therapeutics Inc executives and other stock owners filed with the SEC include:

• Marvin L. White,
  Pres, CEO & Director
• Jeffrey G. Lamothe,
  Sr. VP, CFO & Treasurer
• Dr. Jane A. Gross,
  Sr. VP & Chief Scientific Officer
• Dr. Fatih M. Uckun M.D., Ph.D.,
  Chief Clinical Advisor & Consultant
• SoYoung Kwon J.D., LL.M.,
  Sr. VP, Gen. Counsel, Corp. Affairs & HR
• Censia Pottorf,
  VP of HR
• Heather Boussios,
  Acting Gen. Counsel & Assistant Sec.
• Stacey Jurchison,
  Sr. Director of Investor Relations & Corp. Communications
• Scott C Stromatt,
  Chief Medical Officer and SVP
• Fuad El Hibri,
  Director
• Bio Solutions Inc. Emergent,
  10% owner
• Daphne Taylor,
  SVP, CFO
• Zsolt Harsanyi,
  
• John Niederhuber,
  
• Marvin L White,
  President and CEO
• Daniel Abdun Nabi,
  
• Grady Iii Grant,
  
• Shawnte Mitchell,
  SVP, GC and Corporate Affairs
• Michael Adelman,
  SVP, Commercial Operations
• Jeffrey G. Lamothe,
  EVP, COO
• Jane A Gross,
  SVP & Chief Scientific Officer
• Randy Joe Maddux,
  SVP of Operations, CMO
• Barbara Lopez Kunz,
  
• So Young Kwon,
  SVP, GC, BD & Corp Affairs
• Kevin Ctang Capital Managem...,